about
Molecular basis and characteristics of KATP channel in human corporal smooth muscle cellsA KATP-channel opener as a potential treatment modality for erectile dysfunctionBioactives in Chinese Proprietary Medicine Modulates 5α-Reductase Activity and Gene Expression Associated with Androgenetic AlopeciaThe pharmacological treatment of urinary incontinence.Direct-acting vasodilators.Potassium channel openers: therapeutic potential in cardiology and medicine.Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.Spontaneous phasic activity of the pig urinary bladder smooth muscle: characteristics and sensitivity to potassium channel modulatorsDualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K ATP channel.Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts.Muscle KATP channels: recent insights to energy sensing and myoprotectionInhibitory effects of the ATP-sensitive potassium channel openers cromakalim, pinacidil and minoxidil on the carbachol-response curve in porcine detrusor muscle.Potential therapeutic targets for the treatment of detrusor overactivity.Management of overactive bladder syndromeOnce-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.Possible underestimation of the channel conductance underlying pinacidil-induced K+ currents using noise analysis in pig urethral myocytes.Time-dependent fading of the activation of KATP channels, induced by aprikalim and nucleotides, in excised membrane patches from cardiac myocytes.The effects of drugs modulating K(+) transport on Rb(+) uptake and distribution in pig hearts following regional ischemia: (87)Rb MRI study.Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial.Interaction of isoflurane and cromakalim, a KATP channel opener, on coronary and systemic haemodynamics in chronically instrumented dogs.Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteers.
P2860
Q28203119-A54BFD0B-D9CE-46E1-BD3A-CFC6BF0A154AQ28377738-E750BFAA-E096-4C54-8C31-FE10EC08ABB0Q33559386-07337BA6-517F-449A-AAE0-F5CC4B893FF1Q33778812-F854CD6F-4CEE-481C-9207-D94C5B4EDD7AQ34213900-2A9F35A8-5BD9-4E90-94C1-160874E78724Q34515583-2E6DEAEF-FE27-4C22-9E56-4DE9791BE987Q34793310-CC00D0A4-9873-47D9-A41B-5B894636D47DQ35044074-B0DC3863-3CCC-43D1-AE8F-3D29A4CA5276Q35045276-8B36371F-59B6-4443-B2EA-04313BDBBE27Q35072144-3E3CECC4-23E8-414E-A6DC-F445E53FAFB0Q35076166-688019C0-397C-4BF2-8119-0B057C3095E2Q35642951-51DBFF3A-E3C7-4B3F-A91E-1530CA68D6D0Q35753357-CC82CA96-8E89-477E-848F-25CCE7A206D3Q36875672-86FA0B75-5AAD-4676-82AF-ACDC8376E2E6Q41808926-A4914796-9E82-49AA-AC5D-26A1D4F04B9EQ42499561-50E6DF98-EBF6-4058-BFC2-882C96E5FF4DQ42709923-D95ED644-FFB3-40F0-AC47-E2FF7D5F7191Q44119596-BA1CBEAC-DAD6-420F-AF7D-24985E3A75DAQ49382561-83929CBA-745C-46BE-B7AB-1C313AF82311Q51375475-3588E347-C0C9-4F58-B63F-EA348EFBF5D1Q51555265-C3B0F7F1-FFD9-417E-9DED-0306FD729E1B
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Clinical pharmacology of potassium channel openers.
@ast
Clinical pharmacology of potassium channel openers.
@en
type
label
Clinical pharmacology of potassium channel openers.
@ast
Clinical pharmacology of potassium channel openers.
@en
prefLabel
Clinical pharmacology of potassium channel openers.
@ast
Clinical pharmacology of potassium channel openers.
@en
P2860
P1476
Clinical pharmacology of potassium channel openers.
@en
P2093
Andersson KE
P2860
P304
P356
10.1111/J.1600-0773.1992.TB00466.X
P577
1992-04-01T00:00:00Z